Cargando…
Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017588/ https://www.ncbi.nlm.nih.gov/pubmed/33444512 http://dx.doi.org/10.1164/rccm.202012-4386LE |
| _version_ | 1783674079946997760 |
|---|---|
| author | López-Campos, José Luis Fernández-Villar, Alberto Ruano-Ravina, Alberto |
| author_facet | López-Campos, José Luis Fernández-Villar, Alberto Ruano-Ravina, Alberto |
| author_sort | López-Campos, José Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8017588 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80175882021-04-02 Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect López-Campos, José Luis Fernández-Villar, Alberto Ruano-Ravina, Alberto Am J Respir Crit Care Med Correspondence American Thoracic Society 2021-04-01 2021-04-01 /pmc/articles/PMC8017588/ /pubmed/33444512 http://dx.doi.org/10.1164/rccm.202012-4386LE Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Correspondence López-Campos, José Luis Fernández-Villar, Alberto Ruano-Ravina, Alberto Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title_full | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title_fullStr | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title_full_unstemmed | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title_short | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| title_sort | triple-therapy trials for chronic obstructive pulmonary disease: methodological considerations in the mortality effect |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017588/ https://www.ncbi.nlm.nih.gov/pubmed/33444512 http://dx.doi.org/10.1164/rccm.202012-4386LE |
| work_keys_str_mv | AT lopezcamposjoseluis tripletherapytrialsforchronicobstructivepulmonarydiseasemethodologicalconsiderationsinthemortalityeffect AT fernandezvillaralberto tripletherapytrialsforchronicobstructivepulmonarydiseasemethodologicalconsiderationsinthemortalityeffect AT ruanoravinaalberto tripletherapytrialsforchronicobstructivepulmonarydiseasemethodologicalconsiderationsinthemortalityeffect |